There is no single “best” SSRI for everyone. The most effective option depends on your specific condition, how your body processes the medication, and which side effects matter most to you. That said, large-scale research does show meaningful differences between SSRIs in effectiveness, tolerability, side effects, and drug interactions, and those differences can guide a smarter conversation with your prescriber.
Which SSRIs Work Best for Depression
A landmark analysis published in The Lancet compared 21 antidepressants across 522 trials and over 116,000 patients. Among SSRIs, escitalopram (Lexapro) and paroxetine (Paxil) stood out as more effective than other options for treating major depression. Sertraline (Zoloft) didn’t rank quite as high on raw effectiveness, but it landed in an unusual sweet spot: it combined solid efficacy with above-average tolerability, meaning fewer people quit taking it due to side effects.
For tolerability alone, the SSRIs people were least likely to stop taking were escitalopram, sertraline, citalopram (Celexa), and fluoxetine (Prozac). That matters more than it might sound. An antidepressant you stop taking after three weeks because of nausea or weight gain isn’t helping you, no matter how well it performs in a clinical trial. For this reason, sertraline and escitalopram are the two SSRIs most commonly recommended as starting points for depression treatment.
How SSRIs Differ by Condition
SSRIs aren’t just prescribed for depression. They’re approved for a range of conditions, and certain SSRIs have stronger track records for specific diagnoses.
- Generalized anxiety disorder: Escitalopram and paroxetine both carry approvals here.
- OCD: Fluoxetine, fluvoxamine (Luvox), sertraline, and paroxetine are all approved. Fluvoxamine was actually developed with OCD specifically in mind.
- Panic disorder: Sertraline, paroxetine, and fluoxetine are common choices.
- PTSD: Sertraline and paroxetine are the two SSRIs with specific approval for post-traumatic stress disorder.
- Premenstrual dysphoric disorder (PMDD): Fluoxetine and sertraline are frequently used.
- Social anxiety disorder: Paroxetine and sertraline have approvals for this.
If you’re dealing with more than one of these conditions at the same time, your prescriber will often pick the SSRI that covers both rather than adding a second medication.
Side Effects That Separate Them
Weight Gain
Paroxetine is the clear outlier here. In long-term studies, paroxetine-treated patients gained an average of 3.6% of their body weight, and over 25% of patients gained 7% or more. For someone weighing 160 pounds, that’s gaining 11 or more pounds. Sertraline caused a modest 1% average increase, while fluoxetine actually led to a slight decrease in weight (about 0.2% on average). If weight gain is a concern, fluoxetine and sertraline are more favorable choices.
Sexual Side Effects
Sexual dysfunction is one of the most common reasons people want to switch SSRIs. Paroxetine again ranks worst, with rates around 43% in clinical studies. Across the other SSRIs, rates in younger adults range from about 7% to 30%. Sertraline, citalopram, and escitalopram tend to fall in the middle of that range. Vortioxetine (Trintellix), a newer SSRI-like medication, appears to have lower rates of sexual side effects than the older options, though it works slightly differently in the brain.
Sedation vs. Activation
SSRIs vary in whether they make you feel more sleepy or more wired. Fluoxetine is the most stimulating SSRI, which can be helpful if fatigue and low motivation are your main symptoms, but it can worsen insomnia or anxiety early in treatment. Taking it in the morning helps. Fluvoxamine is the most sedating SSRI and may suit people whose primary complaint is insomnia or agitation. Citalopram, sertraline, and paroxetine fall in the mildly sedating middle ground.
Drug Interactions
If you take other medications, this category matters a lot. SSRIs are broken down by liver enzymes, and some SSRIs block those same enzymes, causing other drugs to build up in your system to potentially dangerous levels.
Paroxetine and fluoxetine are the biggest offenders. Both powerfully inhibit a key liver enzyme called CYP2D6, which processes dozens of common medications including many pain relievers, heart drugs, and other psychiatric medications. Paroxetine can increase blood levels of other drugs processed by this enzyme by 300 to 400%. Fluoxetine is similar, with increases of 380 to 640%. Sertraline and citalopram have far less impact, increasing levels by 0 to 47%. If you’re on multiple medications, sertraline, citalopram, or escitalopram are generally safer bets for avoiding interactions.
Fluoxetine has another wrinkle: its long half-life. The drug and its active breakdown product can linger in your body for one to three weeks after you stop taking it. This is actually an advantage in one respect (it makes missed doses and discontinuation easier), but it means interactions with new medications can persist long after you’ve stopped.
Heart Rhythm Considerations
Citalopram carries the highest risk among SSRIs for a heart rhythm change called QTc prolongation, which in rare cases can trigger dangerous irregular heartbeats. Studies show citalopram extends the QTc interval by about 10.6 milliseconds on average, compared to 7.3 for escitalopram and 3.0 for sertraline. Fluoxetine, paroxetine, and fluvoxamine showed no significant increase. Because of this, the FDA has imposed dose limits on citalopram, particularly for people over 60 or those with existing heart conditions.
Discontinuation and Withdrawal
Stopping an SSRI abruptly can cause discontinuation syndrome: dizziness, nausea, irritability, brain zaps (brief electric-shock sensations), and flu-like symptoms. The risk depends largely on how quickly the drug leaves your body.
Fluoxetine is the easiest SSRI to stop because of its unusually long half-life. Its active metabolite stays in your system for 7 to 15 days, creating a built-in taper. Most other SSRIs have half-lives of about a day or less, meaning levels drop fast when you stop. Paroxetine is notoriously difficult to discontinue, partly because of its short half-life and partly because it inhibits the very enzyme responsible for breaking it down. If you anticipate needing to stop or switch medications at some point, this is worth factoring in from the start.
SSRIs for Children and Teens
Only two SSRIs are FDA-approved for depression in young people: fluoxetine for ages 8 and older, and escitalopram for ages 12 and older. For OCD in children, the options are broader: fluoxetine (ages 7+), fluvoxamine (ages 8+), and sertraline (ages 6+). Fluoxetine has the longest track record in pediatric use and is typically the first choice for depression in this age group.
How Long SSRIs Take to Work
Regardless of which SSRI you start, expect a lag before you feel meaningful improvement. Most people notice some changes in sleep, appetite, or energy within the first one to two weeks, but the full antidepressant or anti-anxiety effect typically takes four to six weeks. Early side effects like nausea, headache, or increased anxiety usually fade during this same window. If you’ve seen no improvement after six to eight weeks at an adequate dose, that particular SSRI likely isn’t the right fit, and switching to another is reasonable.
Putting It Together
If forced to pick the most broadly useful SSRI, most clinicians would point to sertraline or escitalopram. Both combine strong evidence for effectiveness with good tolerability, relatively low drug interaction potential, and approvals across multiple conditions. Sertraline edges ahead for versatility: it covers depression, anxiety, OCD, PTSD, panic disorder, and PMDD, with a mild side effect profile and low interaction risk. Escitalopram is often considered the “cleanest” SSRI, with the fewest off-target effects and a straightforward dosing schedule.
But the right SSRI for you also depends on specifics. If you struggle with fatigue and low energy, fluoxetine’s activating profile may help. If weight gain from a previous medication was a problem, fluoxetine or sertraline are better choices than paroxetine. If you take several other medications, sertraline or escitalopram minimize the risk of interactions. If you’re worried about being able to stop the medication later, fluoxetine’s long half-life makes discontinuation easiest. These tradeoffs are exactly the kind of thing worth discussing openly with whoever is prescribing.